Current Report Filing (8-k)
July 06 2018 - 4:37PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 or 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (date of earliest event reported): July 6, 2018
HealthLynked
Corp.
(Exact Name of Registrant as Specified in its Charter)
Nevada
|
|
47-1634127
|
(State
of Incorporation)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
1726
Medical Blvd., Suite 101, Naples, Florida
|
|
34110
|
(Address
of Principal Executive Offices)
|
|
(ZIP
Code)
|
(239)
513-1992
(Registrant’s
Telephone Number, Including Area Code)
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
|
On
July 1, 2018, HealthLynked Corp. (the “Corporation”) entered into an Extension Letter Agreement (the “Extension”)
to that certain Employment Agreement, originally dated July 1, 2016, by and between the Corporation and Mr. George O’Leary,
the Corporation’s Chief Financial Officer (as extended, the “O’Leary Employment Agreement”). In the extension,
among other things, Mr. O’Leary agreed to increase to full time employment (previously half-time) and agreed to extend the
term of his employment to June 30, 2022. In addition to a base salary, the Extension provides Mr. O’Leary with certain performance-based
cash bonuses, stock grants, and stock option grants.
The
foregoing description of the Extension is not complete and is qualified in its entirety by reference to the full text of the Extension,
a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item
9.01.
|
Financial
Statements and Exhibits.
|
(d)
Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HealthLynked
Corp.
|
|
|
|
Dated:
July 6, 2018
|
By:
|
/s/
George O’Leary
|
|
|
George
O’Leary
|
|
|
Chief
Financial Officer
|
2
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Mar 2024 to Apr 2024
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Apr 2023 to Apr 2024